Intranasal LHRH agonist combined periodically with a progestogen for contraception

A. Lemay, Lemay A
Advances in contraception : the official journal of the Society for the Advancement of Contraception · 1989 · vol. 5(4) , pp. 253–62 · doi:10.1007/bf01890898 · PMID:2517812
Other OA: closed
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-08-28 ⓘ

The paper investigates the use of an intranasal LHRH agonist combined periodically with a progestogen as a method for contraception, without providing specific findings or linking to endometriosis and adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Buserelin Contraceptive Agents, Female Medroxyprogesterone Administration, Intranasal Buserelin Buserelin Contraceptive Agents, Female Drug Evaluation Endometriosis Endometriosis Female Humans Medroxyprogesterone Medroxyprogesterone Menstruation Disturbances Menstruation Disturbances

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-01T09:25:17.647243+00:00
pubmed
last seen: 2026-10-08T21:14:18.823929+00:00
unpaywall
last seen: 2026-11-01T06:18:20.579057+00:00